Department of Gynecology, Charité Universitätsmedizin, Berlin, Germany.
Gynecol Oncol. 2010 Aug 1;118(2):123-7. doi: 10.1016/j.ygyno.2010.04.012. Epub 2010 May 9.
Cervical cancer is the most frequently encountered malignancy during pregnancy. Presence of nodal metastasis is the most important negative prognostic factor and its assessment represents a crucial parameter to decide if pregnancy can safely continue. We describe the results of 18 pregnant patients with cervical cancer who had their nodal status proved by means of laparoscopy.
Eighteen patients with cervical cancer who underwent laparoscopic pelvic lymphadenectomy during pregnancy at Charité-University Berlin and Friedrich-Schiller-University Jena between 1999 and 2010 were analyzed retrospectively.
The mean age at diagnosis was 32 years (26-40) and gestational age between 6 and 23 weeks of pregnancy. The following FIGO stages of cervical cancer were treated: 1a1 for two women, 1a2 for one woman, 1b1 for thirteen women, 1b2 for one woman and 2a for one woman. The histological type was squamous carcinoma in nine cases and adenocarcinoma also in nine cases. All laparoscopic procedures were successfully completed; there was no surgery-associated mortality, morbidity, or conversion to laparotomy. Additionally, there were no complications for either mother or child related to the general anesthesia. The mean number of lymph nodes removed was 17 (6-46). Definitive cancer treatment was delayed for fourteen out of eighteen patients until delivery with an average delay interval of 17 (9-28) weeks. Lymph nodes were positive in 16% of the cases (3/18) and these patients received immediate cancer treatment. One patient decided to interrupt the gestation before delivery despite negative lymph nodes. Fourteen patients reached fetal maturity and gave birth to healthy babies by caesarean section. All patients are alive without evidence of disease at a mean follow-up time of 38 (5-128) months.
Laparoscopic pelvic lymphadenectomy during pregnancy is feasible and safe. Results suggest that in patients with cervical cancer complicated by pregnancy a planned delay of oncologic treatment can be a safe option after tumor metastasis to lymph nodes has been histopathologically ruled out.
宫颈癌是妊娠期最常见的恶性肿瘤。淋巴结转移的存在是最重要的预后不良因素,其评估是决定妊娠是否能安全继续的关键参数。我们描述了在柏林 Charité 大学和耶拿弗里德里希席勒大学,1999 年至 2010 年间,18 例经腹腔镜证实宫颈癌淋巴结状态的孕妇的结果。
回顾性分析了在柏林 Charité 大学和耶拿弗里德里希席勒大学,1999 年至 2010 年间,18 例因宫颈癌而行腹腔镜盆腔淋巴结切除术的孕妇。
诊断时的平均年龄为 32 岁(26-40 岁),妊娠周数为 6-23 周。以下为宫颈癌的 FIGO 分期:2 例为 1a1 期,1 例为 1a2 期,13 例为 1b1 期,1 例为 1b2 期,1 例为 2a 期。组织学类型为 9 例鳞癌和 9 例腺癌。所有腹腔镜手术均顺利完成;无手术相关死亡、发病率或转为剖腹手术。此外,无论是母亲还是孩子,都没有与全身麻醉相关的并发症。切除的淋巴结平均数量为 17 个(6-46 个)。18 例中有 14 例患者因宫颈癌治疗延迟至分娩,平均延迟时间为 17 周(9-28 周)。16%的病例(3/18)淋巴结阳性,这些患者立即接受癌症治疗。尽管淋巴结阴性,1 例患者仍决定在分娩前终止妊娠。14 例患者达到胎儿成熟,通过剖宫产分娩健康婴儿。所有患者在平均 38 个月(5-128 个月)的随访期内均无疾病证据且存活。
妊娠期腹腔镜盆腔淋巴结切除术是可行和安全的。结果表明,对于合并妊娠的宫颈癌患者,如果在组织病理学排除淋巴结转移后,计划延迟肿瘤治疗是安全的选择。